Insider information: Testing cancer drug sensitivity for personalized therapy

被引:2
作者
Wang, Jing [1 ]
Wei, Qiang [1 ]
Ye, Jixing [1 ]
Denduluri, Sahitya K. [1 ]
Wang, Xin [1 ]
Mohammed, Maryam K. [1 ]
Luu, Hue H. [1 ]
Haydon, Rex C. [1 ]
He, Tong-Chuan [1 ]
机构
[1] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
Cancer; Chemotherapy; Drug discovery; Drug resistance; Drug screening; Personalized medicine;
D O I
10.1016/j.gendis.2015.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer death is usually caused by incurable drug-resistant and metastatic cancers. Although tremendous progress has been made in anticancer drug development during the past two decades, cancer medicine still faces unprecedented challenges associated with choosing effective treatments for individual patients. Three recent reports have offered encouraging approaches towards potentially personalized cancer drug selection. Copyright (C) 2015, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:219 / 221
页数:3
相关论文
共 6 条
  • [1] Translational value of mouse models in oncology drug development
    Gould, Stephen E.
    Junttila, Melissa R.
    de Sauvage, Frederic J.
    [J]. NATURE MEDICINE, 2015, 21 (05) : 431 - 439
  • [2] Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
    Hidalgo, Manuel
    Amant, Frederic
    Biankin, Andrew V.
    Budinska, Eva
    Byrne, Annette T.
    Caldas, Carlos
    Clarke, Robert B.
    de Jong, Steven
    Jonkers, Jos
    Maelandsmo, Gunhild Mari
    Roman-Roman, Sergio
    Seoane, Joan
    Trusolino, Livio
    Villanueva, Alberto
    [J]. CANCER DISCOVERY, 2014, 4 (09) : 998 - 1013
  • [3] Cancer drug resistance: an evolving paradigm
    Holohan, Caitriona
    Van Schaeybroeck, Sandra
    Longley, Daniel B.
    Johnston, Patrick G.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (10) : 714 - 726
  • [4] An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
    Jonas, Oliver
    Landry, Heather M.
    Fuller, Jason E.
    Santini, John T., Jr.
    Baselga, Jose
    Tepper, Robert I.
    Cima, Michael J.
    Langer, Robert
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (284) : 284ps10
  • [5] Klinghoffer R. A., 2015, SCI TRANSL MED, V7
  • [6] In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities
    Rubio-Perez, Carlota
    Tamborero, David
    Schroeder, Michael P.
    Antolin, Albert A.
    Deu-Pons, Jordi
    Perez-Llamas, Christian
    Mestres, Jordi
    Gonzalez-Perez, Abel
    Lopez-Bigas, Nuria
    [J]. CANCER CELL, 2015, 27 (03) : 382 - 396